20-63349861-G-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_000744.7(CHRNA4):​c.1550C>G​(p.Ser517Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000416 in 1,442,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S517L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000042 ( 0 hom. )

Consequence

CHRNA4
NM_000744.7 missense

Scores

5
13

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.17

Publications

0 publications found
Variant links:
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
CHRNA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.28956497).
BS2
High AC in GnomAdExome4 at 6 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000744.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
NM_000744.7
MANE Select
c.1550C>Gp.Ser517Trp
missense
Exon 5 of 6NP_000735.1P43681-1
CHRNA4
NM_001256573.2
c.1022C>Gp.Ser341Trp
missense
Exon 5 of 6NP_001243502.1Q4VAQ3
CHRNA4
NR_046317.2
n.1759C>G
non_coding_transcript_exon
Exon 5 of 6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
ENST00000370263.9
TSL:1 MANE Select
c.1550C>Gp.Ser517Trp
missense
Exon 5 of 6ENSP00000359285.4P43681-1
CHRNA4
ENST00000463705.5
TSL:1
n.2198C>G
non_coding_transcript_exon
Exon 4 of 5
CHRNA4
ENST00000467563.3
TSL:1
n.1620C>G
non_coding_transcript_exon
Exon 5 of 6

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000416
AC:
6
AN:
1442928
Hom.:
0
Cov.:
83
AF XY:
0.00000559
AC XY:
4
AN XY:
715124
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33044
American (AMR)
AF:
0.00
AC:
0
AN:
43392
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25280
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39306
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84364
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51450
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.00000545
AC:
6
AN:
1101068
Other (OTH)
AF:
0.00
AC:
0
AN:
59380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.018
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.33
T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.69
T
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.29
T
MetaSVM
Benign
-0.68
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
1.2
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.28
Sift
Uncertain
0.022
D
Sift4G
Uncertain
0.025
D
Polyphen
0.99
D
Vest4
0.29
MutPred
0.29
Loss of phosphorylation at S517 (P = 0.0412)
MVP
0.82
MPC
0.57
ClinPred
0.64
D
GERP RS
2.2
Varity_R
0.12
gMVP
0.27
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45622132; hg19: chr20-61981213; COSMIC: COSV64718782; COSMIC: COSV64718782; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.